Synergistic modulation of FLT3 kinase using aminopyrimidines kinase modulators and a farnesyl transferase inhibitor

Details for Australian Patent Application No. 2006258033 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Gaul, Michael David; Baumann, Christian Andrew

Agent Shelston IP

Pub. Number AU-A-2006258033

PCT Pub. Number WO2006/135713

Priority 60/689,718 10.06.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

International Classifications

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135713 Priority application(s): WO2006/135713

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258034-Sweet potato compositions

2006258032-(5Z)-5-(6-quinoxalinylmethylidene)-2-[(2 ,6-dichlorophenyl)amino]-1,3-thiazol-4(5 H)-one